SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001140361-20-016895
Filing Date
2020-07-29
Accepted
2020-07-28 18:10:49
Documents
3
Group Members
TTP MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A nt10013820x1_sctota.htm SC TO-T/A 33397
2 EXHIBIT (A)(5)(B) nt10013820x1_exa5b.htm EX-99.(A)(5)(B) 13270
3 nt10013820x1_exa5bimage01.jpg GRAPHIC 74671
  Complete submission text file 0001140361-20-016895.txt   151176
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filed by) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Subject) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-87366 | Film No.: 201055054
SIC: 2834 Pharmaceutical Preparations